RxDoctor Payments Data

Stefanie Berg

Physician Assistant · Deposit, NYNPI 1598875866

Payments from drug & device makers

$512in general payments, 2019–2025

Across 26 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$158
  • GSK$157
  • Novo Nordisk$76
  • Corium, LLC$25
  • Exact Sciences$21
  • E.r. Squibb & Sons, L.L.C.$18
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$512100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$512 in reported general payments places this provider in the 65th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$36,178
Medicare patients
210
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$59,669
JardianceEmpagliflozin30$40,820
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$36,698
JanuviaSitagliptin Phosphate20$30,986
FarxigaDapagliflozin Propanediol24$26,803
TrulicityDulaglutide23$24,653
InvokanaCanagliflozin14$22,676
XareltoRivaroxaban11$15,497
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,041
ArexvyRsvpref3 Antigen/As01e/Pf21$6,797
DuleraMometasone/Formoterol12$6,588
Breo ElliptaFluticasone/Vilanterol12$6,248
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$6,226
Albuterol Sulfate HfaAlbuterol Sulfate151$5,670
ShingrixVaricella-Zoster Ge/As01b/Pf24$5,385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Breo Ellipta, Shingrix$157$62,169105 claims
Boehringer IngelheimJardiance$15$40,82030 claims
AstraZenecaFarxiga, Symbicort$14$30,16837 claims
Lilly USA, LLCTrulicity$14$24,65323 claims
AbbVieSynthroid$158$1,01621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Deposit

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →